Conduit Pharmaceuticals reports advancements in lupus studies and trial designs. The Company partnered with Charles River ...

Today, the Lupus Foundation of America announced a new, groundbreaking collaborative lupus clinical trial program – LFA Lupus ...

Differentiated development program includes two Nkarta clinical trials and two investigator-sponsored trials of NKX019 in rheumatic and neurological diseasesInitial data for NKX019 in multiple autoimm ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...